Why We No Longer Like Volpara Health Stock

March 15. 2022. 5 mins read

There are stocks that you want in your portfolio because the technology sounds cool or the company is on a mission to save the world, or because you don’t want to miss out on the latest craze like cryptocurrency or pot stocks. That’s actually called motivation, because there are no inherent good reasons why you would invest in a stock based on these sorts of subjective, emotional reasons. But it happens to the best of us, such as prematurely buying both Desktop Metal (DM) and Ginkgo Bioworks (DNA) based on the excitement around the technology. That’s why we constantly work on developing objective criteria, like our simple valuation ratio for growth stocks or the methodology behind balancing the Nanalyze Disruptive Tech portfolio.

This enables us to revisit and reevaluate these and other companies that we have identified as possible investments in our portfolio with better tools to make rules-based decisions. Today we’re going to take another look at Volpar

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.